Fierce Biotech has named their 2021 “Fierce 15”, which designates the most promising early-stage biotechnology companies in the industry.
Biotechnology Company, Monte Rosa Therapeutics, Inc., announced the pricing of its initial public offering of 11,700,000 shares of common stock .
VC funding update: Boston startups and tech firms raised $3.5B in January
Top 10 Massachusetts VC Deals of 2020
Tessera Therapeutics announced that it has raised over $230M in Series B financing to Advance ‘Gene Writing’ – A New Category in Genetic Medicine.
Cullinan Management announced the pricing of its upsized initial public offering of 11,900,000 shares of common stock.
Starburst has raised $100M in Series C financing led by Andreessen Horowitz.
Largest IPOs of 2020
Servier and Celsius Therapeutics announced a strategic collaboration focused on the identification and validation of novel colorectal cancer (CRC) drug targets.